|
mRNA_ID
|
Gene Name
|
drug_ID
|
drug_Name
|
Disease
|
RNA_exp_pattern
|
Evidence
|
Details
|
|
ENST00000397062
|
NFE2L2
|
NA
|
Tatarinow Sweetflag Extract
|
epilepsy
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
DB17024
|
Chelerythrine
|
aspergillus fumigatus
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
DB00387
|
Procyclidine
|
reproductive dysfunction
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
NA
|
Agathisflavone
|
alzheimer＇s disease
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
DB16101
|
Baicalein
|
alzheimer＇s disease
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
NA
|
Rhoifolin
|
alzheimer＇s disease
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
NA
|
Taraxasterol
|
kidney damage
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
NA
|
NA
|
barrett’s related esophageal adenocarcinoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000397062
|
NFE2L2
|
NA
|
NA
|
lung adenocarcinoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000397062
|
NFE2L2
|
NA
|
NA
|
hepatocellular carcinoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000397062
|
NFE2L2
|
NA
|
NA
|
hepatocellular carcinoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000397062
|
NFE2L2
|
NA
|
NA
|
breast cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000397062
|
NFE2L2
|
NA
|
NA
|
bladder cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000397062
|
NFE2L2
|
NA
|
NA
|
prostate cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000397062
|
NFE2L2
|
NA
|
NA
|
ovarian cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000397062
|
NFE2L2
|
NA
|
NA
|
breast cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000397062
|
NFE2L2
|
NA
|
NA
|
hepatocellular carcinoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000397062
|
NFE2L2
|
DB04216
|
Quercetin
|
neuroinflammation
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
NA
|
Osthole
|
acute lung injury
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
DB11674
|
Equol
|
cardiovascular disease
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
DB11133
|
Omega-3 fatty acids
|
cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
DB06543
|
Astaxanthin
|
cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
DB13751
|
Glycyrrhizic acid
|
chronic liver fibrosis
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
DB12513
|
Omaveloxolone
|
skin disease
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
NA
|
TS-13
|
chronic inflammation
|
down-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
NA
|
Fractalkine
|
tauopathies
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
NA
|
Fractalkine
|
neurodegenerative disease
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
DB02709
|
Resveratrol
|
ventilator-induced lung injury
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
NA
|
|
inflammatory disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
NA
|
Brusatol
|
endotoxemic shock
|
down-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
NA
|
Brusatol
|
sepsis
|
down-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
DB08908
|
Dimethyl fumarate
|
parkinson＇s disease
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
DB11133
|
Omega-3 fatty acids
|
cystic fibrosis
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
NA
|
Lignan phenolics
|
cystic fibrosis
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
DB12412
|
Gemigliptin
|
type 2 diabetic
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
DB08908
|
Dimethyl fumarate
|
lupus nephritis
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
DB15293
|
Epalrestat
|
neuroinflammation
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
DB12422
|
Sulforaphane
|
sickle cell disease
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
DB12513
|
Omaveloxolone
|
cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
NA
|
Oligomeric proanthocyanidin
|
pulmonary fibrosis
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
DB11094
|
Vitamin D
|
non alcoholic fatty liver disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
NA
|
Cyclic helix B peptide
|
renal ischemia reperfusion injury
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
DB08908
|
Dimethyl fumarate
|
sickle cell disease
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
NA
|
Licorice root extract
|
liver injury
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
NA
|
10-oxomornigrol F
|
inflammation
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
DB01132
|
Pioglitazone
|
acute kidney injury
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
DB00862
|
Vardenafil
|
cholestatic liver damage
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
NA
|
6-Shogaol
|
ulcerative colitis
|
down-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
NA
|
Panax quinquefolius saponin
|
cardiovascular disease
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
NA
|
ShenKang Injection
|
diabetic kidney disease
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
NA
|
Kolaviron
|
type-2 diabetes
|
down-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
NA
|
Grape seed proanthocyanidin extract
|
severe asthma
|
down-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
DB01796
|
Quinolinic Acid
|
depressive disorder
|
down-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
DB01188
|
Ciclopirox
|
psoriasis
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
NA
|
Tanshinone IIA
|
renal toxicity
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
NA
|
Ethyl acetate extract of V. ciliata
|
liver injury
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
NA
|
Maggot extract
|
iintestinal fibrosis
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
DB08822
|
Azilsartan medoxomil
|
myocardial hypertrophy
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
NA
|
2-(hydroxyl-(2-nitrophenyl)methyl)cyclopentanone
|
alzheimer＇s disease
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
DB11874
|
Crocin
|
traumatic brain injury
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
DB01236
|
Sevoflurane
|
ischemic stroke
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
NA
|
astragaloside IV
|
cognitive diseases
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
DB12582
|
Piperine
|
multiple sclerosis
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
DB15246
|
Salvianolic acid A
|
diabetic peripheral neuropathy
|
down-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
NA
|
Tilianin
|
diabetic retinopathy
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
DB06655
|
Liraglutide
|
non-alcoholic fatty liver disease
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
DB16101
|
Baicalein
|
chronic periodontitis
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
NA
|
Aureusidin
|
inflammation-related diseases
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
DB05983
|
Bardoxolone methyl
|
chronic kidney disease
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
DB06212
|
Tolvaptan
|
chronic kidney disease
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
DB01234
|
Dexamethasone
|
neurodegenerative disease
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
DB14336
|
Angelica sinensis root (Danggui)
|
prostate cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
DB15584
|
Luteolin (Digitoflavone)
|
colon cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
DB12025
|
Triptolide
|
myeloid leukemia
|
down-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
DB00331 (APRD01099)
|
Metformin
|
cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
NA
|
Tanshinone IIA
|
cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
DB08868
|
Fingolimod (FTY720)
|
glioblastoma
|
down-regulated
|
validated
|
more...
|
|
ENST00000397062
|
NFE2L2
|
NA
|
Chitosan Oligosaccharides
|
renal carcinoma
|
up-regulated
|
validated
|
more...
|